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Introduction
Tuberculosis is a major cause of morbidity and mortality throughout the world. One-third of the world's population is infected with the TB bacillus [1] . The global tuberculosis epidemic results in nearly two million deaths and nine million new cases of the disease per year,95% in developing countries [2] . Once infected active disease develops in about 10% of cases usually within 1-2 years after exposure from TB [3] . The remainder stay in a state of latent tuberculosis infection (LTBI), which can reactivate at a later stage, particularly if the individual is elderly or becomes immune compromised. The simplest rapid method is the detection of acidfast bacilli by microscopy. However, 40 to 60% of patients with pulmonary disease and about 75% of patients with extra-pulmonary disease are smear negative, and in this situation even contemporary culture methods take several weeks to become positive where the diagnosis of tuberculosis relies on the identification of acid-fast bacilli on unprocessed sputum smears using conventional ZiehlNeelsen staining [4] [5] [6] . Acid-fast staining has high specificity in tuberculosis endemic countries, but modest sensitivity which varies among laboratories (range 20% to 80%) [7, 8] . Moreover, the sensitivity is poor for paucibacillary disease (e.g., pediatric and HIV associated tuberculosis) [9] . Thus, the development of rapid and accurate new diagnostic tools is imperative. There are contradictory reports about the diagnostic value of serum adenosine deaminase in tuberculosis. Adenosine deaminase is involved in the propagation and differentiation of various lymphocytes, particularly Tlymphocytes, so that estimation of its level of activity in various body fluids has been used in the diagnosis of tuberculous effusions especially pleural forms [10] . This study was set up to investigate the diagnostic value of serum Adenosin deaminase in diagnosis of tuberculosis because rapid and accurate diagnosis is an important element of TB treatment and control. 
Results
A total of 200 subjects were included in the study designed in four groups(Sm+,Sm-,Ex-pul. And CAP). 22(44%) males and 28(56%) females with a mean age of 52.96 ± 22.14 were diagnosed as group I, 29(58%)males and 21(42%) females with a mean age of 59.10 ± 18.29 were diagnosed as group II, 23(46%) males, 27(54%) females with a mean age of 56.14 ± 20.69 were diagnosed as group III and 26(52%) males , 24(48%) females with a mean age of 58.94 ± 17.58 were diagnosed as group IV.The mean value for serum ADA level that determined in Sm+, Sm&minus, Ex-pul. And CAP patients were 18.09 ± 6.64, 17± 5.10, 18.74± 3.45 and 15.55 ± 4.55 U/lit respectively.
In One-way Analysis of Variance (ANOVA) of mean differences of four groups the differences between group III (Ex-pul.) and group IV (CAP) was significant. (P-value =0.0115) ( Table 1 Considering the cutoff value of 24 U/l for ADA in group I defined the sensitivity, specificity, positive predictive value and negative Page number not for citation purposes 3 predictive value 12% , 98%, 86%, and 56% respectively .group II defined the 6% , 98% , 75% and 51% and group III defined the 14% , 98% , 88% and 53% respectively. (Table 3) 
Discussion
In our study, no significant differences in age, sex, place of residence and compared the serum levels of ADA in four groups were not found significant differences. Several studies were carried out, have suggested the use of serum ADA levels for the diagnosis of pulmonary tuberculosis. Thora et al. [11] studied ADA levels of 100 newborn sera who were vaccinated with BCG showing a significant increase, indicating human cell-mediated immune response against mycobacterium antigens. Mishra et al. [12] evaluated serum ADA levels of 51 children with confirmed tuberculosis (pulmonary, peritoneal, meningeal, and bone), and 20 healthy controls showing significant increase in the first group with a p-value of <0.001. Collazos et al. [13] performed a prospective follow up study of 25 cases of pulmonary and pleural tuberculosis with a normal immune response for a period of 6 months after initiation of treatment. There was a significant decline in the serum ADA values during the first two months in the patients as a whole (P=0.04), followed by stabilization of the serum ADA activity .This decline was due to a marked decrease in the serum ADA activity in 13patients (52%) who had initial high levels of enzyme (p=0.03), whereas there were no changes in those patients with normal initial levels (p=0.27). Similar results were obtained by Ishii et al. [14] in Japan together with a direct association between serum ADA level and erythrocyte sedimentation rate. Joshaghani et al. [15] showed that the assessment of these enzymes in serum to some extend can be a useful method for differentiation of healthy subjects from respiratory disease, but these tests do not have enough sensitivity to assist in the diagnoses of tuberculosis patients from other respiratory diseases. Conde et al. [16] evaluated serum ADA in active pulmonary tuberculosis and other pulmonary infections and showed no significant difference between them. Their results were in disagreement with the report by Yasuhara et al. [17] in which serum ADA activity of children with active pulmonary tuberculosis was found to be significantly greater than those with bacterial or viral pneumonia. Serum activity of ADA has good specificity and positive predictive value. For several years, the ability to differentiate the diagnosis of PTB and non-PTB was an important issue for clinicians. Serum ADA activity is one such method, for which there have been varying results. Lamsal et al. [18] found a cut-off value of 25 U/L, a test sensitivity of 72.41%, and a specificity of 81.53%. Kuyucu et al. [19] reported a serum ADA level of greater/equal to 53.76 U/L, a sensitivity of 100%, and a specificity of 90.7%, while indicating a positive predictive value of 58.8%, and a negative predictive value of 100% in children with TB.
Bhargave et al. [20] and Al-Shammary et al. [21] reported the cutoff value of serum ADA levels in tuberculosis patients as 78.12 IU/L and 32.8 U/L, respectively
Conclusion
In our study, the optimum cut-off point of ADA for distinguishing tuberculosis and non-tuberculosis subjects was found to be >24 U/L using the ROC curve and has low sensitivity, high specificity in 
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